skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies

Review

(3138) Views  (459) Full article downloads

Authors: Prashant Gajwani, David J Muzina, David E Kemp, Keming Gao, Joseph R Calabrese

Published Date January 2007 Volume 2007:3(6) Pages 847 - 853
DOI: http://dx.doi.org/10.2147/NDT.S1636

Prashant Gajwani1, David J Muzina2, David E Kemp3, Keming Gao1, Joseph R Calabrese1

1Case Western Reserve University (CWRU) School of Medicine, 2Cleveland Clinic Lerner College of Medicine of CWRU, 3Case Western Reserve University, Cleveland OH, USA

Abstract: The essential features of bipolar affective disorder involve the cyclical occurrence of high (manic or hypomanic episodes) and low mood states. Depressive episodes in both bipolar I and II disorder are more numerous and last for longer duration than either manic or hypomanic episodes. In addition depressive episodes are associated with higher morbidity and mortality. While multiple agents, including all 5 atypical antipsychotics, have demonstrated efficacy and earned US FDA indication for manic phase of bipolar illness, the acute treatment of bipolar depression is less well-studied. The first treatment approved by the US FDA for acute bipolar depression was the combination of the atypical antipsychotic olanzapine and the antidepressant fluoxetine. Recently, quetiapine monotherapy has demonstrated efficacy in the treatment of depressive episodes associated with both bipolar I and II disorder and has earned US FDA indication for the same.

Keywords: bipolar disorder, quetiapine, BOLDER studies








Readers of this article also read:

Bipolar disorders: treatment options and patient satisfaction
Quetiapine in the treatment of schizophrenia
Quetiapine monotherapy for bipolar depression
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
"If we only got a chance.” Barriers to and possibilities for a more health-promoting health service
Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma
Traditional and new strategies in the primary prevention of eating disorders: a comparative study in Spanish adolescents
Obesity and respiratory diseases
Reorientation to more health promotion in health services – a study of barriers and possibilities from the perspective of health professionals